SEC Filing Details
Document Details
Form
Filing Date
Aug 28, 2024
Document Date
Aug 26, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
ARS Pharmaceuticals
Issuer
ARS PHARMACEUTICALS, INC.
Filer
ORBIMED ADVISORS LLC